Biography

Dr. Zhiwei Hu

College of Medicine, Department of Surgery

The OSU James Comprehensive Cancer Center

The Ohio State University

Associate Professor


Email: [email protected]


Qualifications

1997 Ph. D., Hunan Medical University, Tumor Immunobiology

1994 M. S., Jiangxi Medical College, Tumor Immunology

1991 M. D., Jiangxi Medical College, Medicine and Stomatology


Publications (selected)

  1. Ahmed, N., Jabeen, J., Noor, S., et al. (2026). Evaluation of Efficacy and Safety of Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cells in Breast Cancer: A Systematic Review and Meta-Analysis. Cancers, 18(10), Article 1634.
  2. Hu, Z., Wu, J., Yang, Q., et al. (2025). New Insight into the Quantifying Vacancy Distribution in Self-Ion-Irradiated Tungsten: A Combined Experimental and Computational Study. Nano Letters, 25(27), 10787–10793.
  3. Mamillapalli, R., Krikun, G., Nimisha, G., et al. (2025). TF-CAR-NK Cells as an Immunotherapy for Endometriosis. Reproductive Sciences, 32(1), Article 52A.
  4. Ancel, J., Bergantini, L., Mendogni, P., et al. (2025). Thoracic Malignancies: From Prevention and Diagnosis to Late Stages. Life, 15(2), Article 138.
  5. Hu, Z., & Bousbaa, H. (2025). Recent advances in anticancer strategies. Cancers, 17(2), Article 173.
  6. Hu, Z., Yang, Q., Jomard, F., et al. (2024). Revealing the role of oxygen on the defect evolution of electron-irradiated tungsten: A combined experimental and simulation study. Journal of Nuclear Materials, 602, Article 155353.
  7. Wu, J., Balbuena, J. P., Hu, Z., et al. (2024). High-dose long-time defect evolution in tungsten studied by atomistically informed Object Kinetic Monte Carlo simulations. arXiv preprint arXiv:2409.15856.
  8. Hu, Z. (2024). Vacancy Defects Distribution in Self-Ion Irradiated Molybdenum. Scientific Books of Abstracts, 4, 21–21.
  9. Lai, E., Ziranu, P., Pezzella, F., et al. (2024). Angiogenesis and access to vasculature as a target in gastrointestinal tumors and predictive biomarkers identification: an open challenge. Frontiers in Oncology, 14, Article 1428174.
  10. Hu, Z. (2024). Methods and compositions related to a tissue factor-targeting igg3 immunoconjugates (U.S. Patent Application No. 18/529,638). U.S. Patent and Trademark Office.
  11. Hu, Z. (2024). Methods and compositions related to a tissue factor-targeting IGG3 immunoconjugates (U.S. Patent No. 11,872,194). U.S. Patent and Trademark Office.
  12. Meng, L., Collier, K. A., Wang, P., et al. (2023). Emerging immunotherapy approaches for advanced clear cell renal cell carcinoma. Cells, 13(1), Article 34.
  13. Wang, H., Zhang, H., Wang, Y., et al. (2021). Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis. Journal of Hepatology, 75(6), 1271–1283.
  14. Zhang, H., Wang, Y., Onuma, A., et al. (2021). Neutrophils extracellular traps inhibition improves PD-1 blockade immunotherapy in colorectal cancer. Cancers, 13(21), Article 5333.
  15. Ren, J., He, J., Zhang, H., et al. (2021). Platelet TLR4-ERK5 axis facilitates NET-mediated capturing of circulating tumor cells and distant metastasis after surgical stress. Cancer Research, 81(9), 2373–2385.
  16. Hu, Z. (2021). Using CAR-NK cells to overcome the host resistance to antibody immunotherapy and immune checkpoint blockade therapy. In Successes and Challenges of NK Immunotherapy (pp. 193–212). Academic Press.
  17. Hufnagel, D., Goetz, L. G., Hu, Z., et al. (2020). Corrigendum to "Icon immunoconjugate treatment results in regression of red lesions in a non-human primate (Papio anubis) model of endometriosis" [Reprod. Biol. 18 (2018) 109-114]. Reproductive Biology, 20(4), 600.
  18. Gomez, S., Tsung, A., & Hu, Z. (2020). Current targets and bioconjugation strategies in photodynamic diagnosis and therapy of cancer. Molecules, 25(21), Article 4964.
  19. Hu, Z. (2020). Tissue factor as a new target for CAR-NK cell immunotherapy of triple-negative breast cancer. Scientific Reports, 10(1), Article 2815.
  20. Zhang, H., Xia, Y., Hu, Z., et al. (2019). Preoperative exercise therapy protects the liver from ischemia-reperfusion injury. Hepatology, 70, Article 1255A.


Profile Details
https://scholar.google.com/citations?user=xOM1_3wAAAAJ&hl=en
https://cancer.osu.edu/find-a-researcher/search-researcher-directory/zhiwei-hu-100003209

WOS ResearcherID: L-3727-2013

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top